| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRI | Common Stock | Options Exercise | $130,036 | +1,551 | +17% | $83.84 | 10,496 | 06 May 2021 | Direct | |
| transaction | CRI | Common Stock | Sale | $220,273 | -2,019 | -19% | $109.10 | 8,477 | 06 May 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRI | Employee Stock Option (Right to Purchase) | Options Exercise | $0 | -1,551 | -100% | $0.000000* | 0 | 06 May 2021 | Common Stock | 1,551 | $83.84 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | This is a weighted average price. The shares were sold in multiple trade executions at prices ranging from $109.04 to $109.12 inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| F2 | Some of these shares are restricted shares that are subject to either time-vesting or performance-based restrictions. |
| F3 | These time-vesting options are exercisable in four equal annual installments beginning one year from the grant date. |